Searched for
PATENT LITIGATION
US firm ContentNexus files patent suit against WiproA US patent holder has sued Wipro in a federal court. The company alleges Wipro used patented technology without permission. This involves ...- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
- Zydus settles US Mirabegron patent dispute with Astellas for $120 millionZydus Lifesciences and its US subsidiary have settled patent litigation with Astellas Pharma over Astellas' Myrbetriq. Zydus will pay Astel...
- Nokia and China's Oppo resolve disputes through cross-license dealNokia has signed a 5G patent cross-licensing agreement with Chinese device maker Oppo, resolving patent litigation between the two companie...
- AutoStore and Ocado reach deal to settle patent litigation claimsNorwegian robotics firm AutoStore will pay 200 million pounds ($257.1 million) to British online supermarket group Ocado as part of a deal ...
- Sun Pharma settles patent litigation with Celgene Corporation for cancer drug RevlimidDrug major Sun Pharma has reached an agreement with Celgene Corporation, to resolve the patent litigation regarding generic version of Revl...
- Sun Pharma inches up as the company settles a patent litigationPursuant to the terms of the settlement, Celgene will grant Sun Pharma a licensc to Celgene’s patents required to manufacture and sell (sub...
- Natco settles patent litigation with Celgene on cancer drugNatco and its US partner Allergan have settled a pending litigation with Celgene regarding generic Lenalidomide capsules used for treatment...
- Glenmark Pharmaceuticals settles patent litigation over anti-depressant drugGlenmark Pharmaceuticals announced a patent litigation settlement with Forest Laboratories and Royalty Pharma Collection Trust over anti-de...
- Sun Pharma settles patent litigation with Acorda TherapeuticsSun Pharma has settled patent litigation with Acorda Therapeutics over Ampyra extended-release tablets, which is used in the treatment of m...
- Cipher, Ranbaxy settle patent litigation with ActavisCipher Pharma Inc, along with partners Ranbaxy - a Sun Pharma firm - and Galephar Pharmaceutical Research, has entered into a patent litiga...
- Vendors launching low cost 4G devices may breach patents: ExpertsEricsson and, which together hold a majority of patents related to 4G technology, have warned potential offenders of litigation in case of ...
- Higher legal risks involved in the 4G ecosystem compared to 3G: Experts“In telecom, patent litigation is going to be huge all across the world and India is no exception,” said Pavan Duggal, a leading cyber law ...
- Huawei to do 'anything it takes' to protect its patents“As much as we respect others IPR, we will do anything that it takes to protect our own patents as well,” said Huawei India's P Sanjeev.
- Samsung Electronics settles patent litigation with InterdigitalThe deal resolves litigation between Interdigital and Samsung at the US International Trade Commission and in federal court in Delaware.
- Warner Chilcott & Cadila Healthcare settles patent litigationIndia's fifth largest drug maker by revenue, Zydus Cadila Group has settled a patent litigation with US-based Warner Chilcott Company LLC.
- Intas settles patent litigation with Hoffmann-La Roche for capecitabine tabletAhmedabad-based drug maker, Intas Pharmaceuticals Ltd and its US-based wholly owned subsidiary Accord Healthcare Inc. has entered into a se...
- Ranbaxy settles drug dispute with Takeda, US launch in 2012Ranbaxy Laboratories Ltd on Monday said it has entered into an agreement with the Japanese drug maker Takeda Pharmaceuticals for ending the...
- Ranbaxy Labs settles Imitrex patent litigationRanbaxy Laboratories has settled all matters relating to possible patent litigation with GlaxoSmithKline relating to Sumatriptan Succinate ...
- Wockhardt challenges patents litigationWockhardt Pharma has just got into the game. The co is challenging Abbott Lab patent on epilepsy drug.
Load More
